Keywords: immunomedics, cea, -scan, following, 208-patient, phase, iii

Immunomedics CEA -Scan

Article | 05 June 1995

- Following a 208-patient US Phase III study, Immunomedics has announced that its diagnostic imaging agent, CEA-Scan (Tc-labelled Fab fragment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in